BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32406300)

  • 1. Infection-related hospitalization after intensive immunosuppressive therapy among lupus nephritis and ANCA glomerulonephritis patients.
    Yin P; Li J; Wen Q; Qiu Y; Liang W; Wang J; Yu J; Zhong Z; Yang X; Yu X; Ye Q; Huang F
    Ren Fail; 2020 Nov; 42(1):474-482. PubMed ID: 32406300
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody.
    Wang S; Shang J; Xiao J; Zhao Z
    Ren Fail; 2020 Nov; 42(1):244-254. PubMed ID: 32228220
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinicopathologic Characteristics and Outcomes of Lupus Nephritis With Antineutrophil Cytoplasmic Antibody: A Retrospective Study.
    Wang Y; Huang X; Cai J; Xie L; Wang W; Tang S; Yin S; Gao X; Zhang J; Zhao J; Huang Y; Li Y; Zhang Y; Zhang J
    Medicine (Baltimore); 2016 Jan; 95(4):e2580. PubMed ID: 26825903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
    Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
    Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum antineutrophil cytoplasmic antibody positivity at the time of renal biopsy is associated with disease activity of lupus nephritis.
    Zhang J; Lian R; Chen Y; Wan J
    Ren Fail; 2024 Dec; 46(2):2357743. PubMed ID: 38847502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study.
    Li C; Zhou ML; Liang DD; Wang JJ; Yang J; Zeng CH; Liu ZH; Zhang HT
    BMJ Open; 2017 Jul; 7(7):e015668. PubMed ID: 28756384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of different hepatitis B infection status on the prognosis of active lupus nephritis treated with immunosuppression: a retrospective analysis of 177 patients.
    Fang J; Li W; Tan M; Peng X; Tan Z; Wang W
    Int J Rheum Dis; 2018 May; 21(5):1060-1067. PubMed ID: 29878614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis.
    Tesar V; Masek Z; Rychlík I; Merta M; Bartůnková J; Stejskalová A; Zabka J; Janatková I; Fuciková T; Dostál C; Becvár R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1662-7. PubMed ID: 9681708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronicity index, especially glomerular sclerosis, is the most powerful predictor of renal response following immunosuppressive treatment in patients with lupus nephritis.
    Park DJ; Choi SE; Xu H; Kang JH; Lee KE; Lee JS; Choi YD; Lee SS
    Int J Rheum Dis; 2018 Feb; 21(2):458-467. PubMed ID: 29314776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden.
    Mohammad AJ; Weiner M; Sjöwall C; Johansson ME; Bengtsson AA; Ståhl-Hallengren C; Nived O; Eriksson P; Sturfelt G; Segelmark M
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i23-30. PubMed ID: 25540097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis.
    Hogan SL; Satterly KK; Dooley MA; Nachman PH; Jennette JC; Falk RJ
    J Am Soc Nephrol; 2001 Jan; 12(1):134-142. PubMed ID: 11134259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANCA-associated glomerulonephritis in the very elderly.
    Bomback AS; Appel GB; Radhakrishnan J; Shirazian S; Herlitz LC; Stokes B; D'Agati VD; Markowitz GS
    Kidney Int; 2011 Apr; 79(7):757-64. PubMed ID: 21160463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids are the major contributors to the risk for serious infections in autoimmune disorders with severe renal involvement.
    Obrișcă B; Vornicu A; Jurubiță R; Achim C; Bobeică R; Andronesi A; Sorohan B; Herlea V; Procop A; Dina C; Ismail G
    Clin Rheumatol; 2021 Aug; 40(8):3285-3297. PubMed ID: 33595739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis.
    Yu F; Tan Y; Liu G; Wang SX; Zou WZ; Zhao MH
    Kidney Int; 2009 Aug; 76(3):307-17. PubMed ID: 19404274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe infections in patients with lupus nephritis treated with immunosuppressants: A retrospective cohort study.
    Lim CC; Liu PY; Tan HZ; Lee P; Chin YM; Mok IY; Chan CM; Choo JC
    Nephrology (Carlton); 2017 Jun; 22(6):478-484. PubMed ID: 27148694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification for infection during immunosuppressive therapy in patients with lupus nephritis: A nested case-control study.
    Lu J; Wu Y; Xue J; Hao C
    Lupus; 2024 Jul; 33(8):828-839. PubMed ID: 38662532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic antibody negative pauci-immune extracapillary glomerulonephritis.
    Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Mollejo M; Fernandez-Juarez G
    Nephrology (Carlton); 2016 Apr; 21(4):301-7. PubMed ID: 26369898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed lupus nephritis in the course of systemic lupus erythematosus is associated with a poorer treatment response: a multicentre, retrospective cohort study in Japan.
    Nakano M; Kubo K; Shirota Y; Iwasaki Y; Takahashi Y; Igari T; Inaba Y; Takeshima Y; Tateishi S; Yamashita H; Miyazaki M; Sato H; Kanda H; Kaneko H; Ishii T; Fujio K; Tanaka N; Mimori A
    Lupus; 2019 Aug; 28(9):1062-1073. PubMed ID: 31296139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination immunosuppressant therapy and lupus nephritis outcome: a hospital-based study.
    Chen YM; Hung WT; Liao YW; Hsu CY; Hsieh TY; Chen HH; Hsieh CW; Lin CT; Lai KL; Tang KT; Tseng CW; Huang WN; Chen YH
    Lupus; 2019 Apr; 28(5):658-666. PubMed ID: 30971165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.